No connection

Search Results

DLB

BEARISH
$64.08 Live
Dolby Laboratories, Inc. · NYSE
$57.62 52W Range $78.28

At a glance

Key valuation, profitability, growth, and risk metrics.

Updated Apr 26, 2026
Market cap
$6.12B
P/E
25.94
ROE
N/A
Profit margin
N/A
Debt/Equity
N/A
Dividend yield
2.15%

AI Analysis

AI-powered fundamental assessment

Confidence
80%
DLB exhibits significant financial deterioration as evidenced by a weak Piotroski F-Score of 2/9 and a Technical Trend score of 0/100. While the company maintains a strong track record of beating earnings estimates, this is offset by negative YoY EPS growth (-7.0%) and a consistent multi-year price decline (5Y Change: -31.1%). Heavy insider selling, particularly by the CEO, combined with a low dividend strength score, suggests a lack of internal confidence despite a seemingly attractive Forward P/E of 13.83.

Key Strengths

Consistent history of beating quarterly earnings estimates (3/4 last 4 quarters)
High average earnings surprise (18.83% over last 4 quarters)
Attractive Forward P/E (13.83) compared to Trailing P/E (25.94)
Established market position in consumer electronics and digital media
Positive most recent Q/Q EPS growth (+7.1%)

Key Risks

Severe financial health deterioration (Piotroski F-Score 2/9)
Strong bearish insider sentiment with significant CEO selling
Negative long-term price performance across 1Y, 3Y, and 5Y horizons
Negative YoY EPS growth (-7.0%) and negative Q/Q revenue growth (-2.88%)
Weak dividend strength (20/100) and low technical momentum
AI Fair Value Estimate
Based on comprehensive analysis
$58.0
-9.5% below current price

Performance Snowflake

Multi-dimensional analysis across 5 key categories

Overall
32
Weak
Value
55
Future
35
Past
20
Health
22
Dividend
30
AI Verdict
Underperform
Key drivers: Piotroski F-Score, Insider Selling, Long-term Price Decay, Negative YoY Growth
Confidence
85%
Value
55/100

Ref P/E 25.94, Forward P/E 13.83

Positives
  • Forward P/E is significantly lower than trailing P/E
Watchpoints
  • P/B of 2.36 is moderate but not a deep value play
Future
35/100

Ref Growth rates

Positives
  • Recent Q/Q EPS growth is positive
Watchpoints
  • Negative YoY EPS growth
  • Negative Q/Q revenue growth
Past
20/100

Ref Historical trends

Positives
  • Strong history of earnings beats
Watchpoints
  • 5Y change of -31.1%
  • 3Y change of -18.3%
Health
22/100

Ref Piotroski F-Score

Positives
No standout positives identified.
Watchpoints
  • Piotroski F-Score of 2/9 indicates weak financial health
Dividend
30/100

Ref Yield 2.15%

Positives
  • Maintains a 2.15% yield
Watchpoints
  • Dividend strength score is very low (20/100)

Stock Price & Analyst Targets

Real-time price movements and analyst price targets

Current Price
$64.08

Multi-Horizon Performance vs Peers

Price momentum across 5Y → 1W horizons for DLB and closest competitors.

Updated 2026-04-24
DLB
Dolby Laboratories, Inc.
Primary
5Y
-31.1%
3Y
-18.3%
1Y
-13.8%
6M
-3.8%
1M
+9.3%
1W
-0.9%

Positive values indicate cumulative gains over the specified period. Comparables pulled from the same sector to highlight whether momentum is stock-specific or industry-wide.

Historical Performance Trends

Long-term financial metrics and growth patterns

Revenue & Net Income

Profit & Operating Margins

Return on Equity (ROE)

Quarterly Revenue Growth

Historical data shows last 12 quarters (3 years)

Valuation Metrics

Key valuation ratios and pricing indicators

P/E Ratio
25.94
Forward P/E
13.83
PEG Ratio
N/A
P/B Ratio
2.36
P/S Ratio
N/A
EV/Revenue
N/A
EV/EBITDA
N/A
Market Cap
$6.12B

Profitability

Profit margins and return metrics

Profit Margin N/A
Operating Margin N/A
Gross Margin N/A
ROE N/A
ROA N/A

Growth

Revenue and earnings growth rates

Revenue Growth N/A
Earnings Growth N/A
Q/Q Revenue Growth -2.88%
Q/Q Earnings Growth N/A

Financial Health

Balance sheet strength and liquidity metrics

Debt/Equity
N/A
Current Ratio
N/A
Quick Ratio
N/A
Cash/Share
$N/A

Financial Statement Flow

Interactive flow visualization showing how money moves through the company Q4 2025

Revenue
$0.3B
Gross Margin
87.5%
Op. Margin
20.9%
Net Margin
15.4%
Total Assets
$3.2B
Liabilities
$0.6B
Equity
$2.6B
Debt/Equity
0.23x
Operating CF
$0.1B
CapEx
$-0.0B
Free Cash Flow
$0.0B
FCF Yield
90%

Quarterly Earnings History

EPS performance vs analyst estimates

2026-04-30
$N/A
2026-01-29
$1.06
+6.7% surprise
2025-11-18
$0.99
+40.4% surprise
2025-07-31
$0.78
+9.3% surprise

Recent Insider Trading

Insider buy and sell transactions from the last 6 months

ROLLINS EMILY
Director
Sell
2026-04-01
1,000 shares · $60,080
DOLBY DAGMAR
Beneficial Owner of more than 10% of a Class of Security
Gift
2026-02-25
10,000 shares
DOLBY DAGMAR
Beneficial Owner of more than 10% of a Class of Security
Stock Award
2026-02-25
10,000 shares
REVANKAR SHRIRAM
Officer
Sell
2026-02-17
3,000 shares · $198,420
NICHOLSON RYAN
Officer
Sell
2026-02-13
2,667 shares · $177,023
NICHOLSON RYAN
Officer
Option Exercise
2026-02-13
2,667 shares · $121,348
DOLBY DAGMAR
Beneficial Owner of more than 10% of a Class of Security
Gift
2026-02-11
380,000 shares
DOLBY DAGMAR
Beneficial Owner of more than 10% of a Class of Security
Stock Award
2026-02-11
380,000 shares
PROPHET TONY A
Director
Stock Award
2026-02-03
3,908 shares
SEGARS SIMON
Director
Stock Award
2026-02-03
3,908 shares
SUD ANJALI
Director
Stock Award
2026-02-03
3,908 shares
ROLLINS EMILY
Director
Stock Award
2026-02-03
3,908 shares
GOTCHER PETER C
Director
Stock Award
2026-02-03
3,908 shares
TEVANIAN AVADISJR
Director
Stock Award
2026-02-03
3,908 shares
DOLBY DAVID
Director and Beneficial Owner of more than 10% of a Class of Security
Stock Award
2026-02-03
3,908 shares
Insider transactions can signal confidence or concerns about company prospects

SEC Filings

Recent regulatory filings from the SEC EDGAR database

8-K
8-K
2026-02-06

DLB filed an 8-K on February 6, 2026, likely to announce its annual financial results for the fiscal year ended December 31, 2025.

10-Q
10-Q
2026-01-29

DLB filed its 10-Q on January 29, 2026, though the provided excerpt contains no specific financial performance data. The filing references Risk Factors under Item 1A, but detailed risks were not disclosed in the available text.

8-K
8-K
2026-01-29

DLB filed an 8-K on January 29, 2026, likely to announce its year-end financial results or a material corporate update.

DEF 14A
DEF 14A
2025-12-16

DLB filed a Definitive Proxy Statement (DEF 14A) on December 16, 2025, providing shareholders with necessary information to vote on corporate matters at the upcoming annual meeting.

10-K
10-K
2025-11-18

DLB filed its 10-K on November 18, 2025, which includes standard disclosures on risk factors, management’s discussion and analysis, and consolidated financial statements. While specific financial metrics were not provided in the excerpts, the filing covers the company's operations within consumer electronics and digital media technologies.

8-K
8-K
2025-11-18
8-K
8-K
2025-11-14

DLB filed an 8-K on November 14, 2025, likely to announce its third-quarter financial results.

10-Q
10-Q
2025-07-31

DLB submitted its 10-Q filing on July 31, 2025. While the document includes a section for risk factors under Item 1A, specific financial highlights and detailed risk disclosures were not provided in the available excerpt.

8-K
8-K
2025-07-31

DLB filed an 8-K on July 31, 2025, likely to report its second-quarter financial results.

10-Q
10-Q
2025-05-01

DLB filed its 10-Q on May 1, 2025. The provided excerpt identifies the presence of Risk Factors under Item 1A, although specific financial highlights and detailed risk disclosures were not included in the available text.

8-K
8-K
2025-05-01
8-K
8-K
2025-02-07
10-Q
10-Q
2025-01-30
8-K
8-K
2025-01-29
DEF 14A
DEF 14A
2024-12-20
Data sourced from SEC EDGAR. AI summaries generated automatically.

Wall Street Analysts

Professional analyst ratings and price targets

Barrington Research
2026-01-30
Maintains
Outperform Outperform
Rosenblatt
2026-01-30
Maintains
Buy Buy
Barrington Research
2026-01-26
Maintains
Outperform Outperform
Rosenblatt
2026-01-22
Maintains
Buy Buy
Rosenblatt
2025-11-19
Maintains
Buy Buy
Barrington Research
2025-11-19
Maintains
Outperform Outperform

Past News Coverage

Recent headlines mentioning DLB from our newsroom.

Newest → oldest
TradingGPT V2 Copilot
Fundamentals • Valuation • Risk
Hi! I'm your fundamentals copilot.

Ask me to:
• Summarize the business quality
• Review valuation and multiples
• Highlight risks and red flags
• Explain growth and margin trends
Home
Terminal
AI Chat
Markets
Profile